progress-
Pipeline
| Product / technology (target/biomarker) | Discovery stage | Development | Scale-up | Commercialization | Commercial partner | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Proof-of-concept | Pre-clinic data | Clinical validation | CE / IVDR | Market | ||||||||||||
![]() | ||||||||||||||||
| Product / technology (target/biomarker) | Discovery stage | Development | Scale-up | Commercialization | Commercial partner | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Proof-of-concept | Pre-clinic data | Clinical validation | CE / IVDR | Market | ||||||||||||
![]() | ||||||||||||||||
GeneSpector s.r.o.
Petrska 1180/3 110 00 Prague, Czech Republic
ID No / IČO: 09404546, file number C 335854
administered by the Municipal Court in Prague
General queries,
investors & partners
EU subsidiary
GeneSpector s.r.o.
Petrska 1180/3
110 00 Prague, Czech Republic
ID No / IČO: 09404546
File number C 335854
administered by
the Municipal Court in Prague